Post job

Competitor Summary. See how BioNumerik Pharmaceuticals compares to its main competitors:

  • Amylin Pharmaceuticals has the most employees (1,300).
Work at BioNumerik Pharmaceuticals?
Share your experience

BioNumerik Pharmaceuticals vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
1992
4.0
San Antonio, TX1$4.5M50
1991
4.8
Cambridge, MA1$118.8M380
1987
4.6
San Diego, CA1$650.7M1,300
Technology Assesment & Transfer
1991
3.1
Annapolis, MD1$1.5M15
1983
4.0
Washington, DC1$4.3M46
Product Safety Engineering
-
3.8
Dade City, FL1$370,00010
1999
4.6
South San Francisco, CA2$174.4M535
1988
4.1
Durham, NC1$28.9M200
1976
3.9
Salt Lake City, UT1$9.6M100

Rate BioNumerik Pharmaceuticals' competitiveness in the market.

Zippia waving zebra

BioNumerik Pharmaceuticals salaries vs competitors

Compare BioNumerik Pharmaceuticals salaries vs competitors

CompanyAverage salaryHourly salarySalary score
BioNumerik Pharmaceuticals
$57,963$27.87-

Compare BioNumerik Pharmaceuticals job title salaries vs competitors

CompanyHighest salaryHourly salary
BioNumerik Pharmaceuticals
$94,294$45.33
Amylin Pharmaceuticals
$96,530$46.41
Ariad Pharmaceuticals
$94,240$45.31
Fluidigm
$84,845$40.79
Ceramatec
$75,522$36.31
Cato Research
$62,687$30.14
Technology Assesment & Transfer
$61,136$29.39
Product Safety Engineering
$56,370$27.10
OPX
$46,450$22.33

Do you work at BioNumerik Pharmaceuticals?

Is BioNumerik Pharmaceuticals able to compete effectively with similar companies?

BioNumerik Pharmaceuticals jobs

BioNumerik Pharmaceuticals demographics vs competitors

Compare gender at BioNumerik Pharmaceuticals vs competitors

Job titleMaleFemale
Ariad Pharmaceuticals61%39%
BioNumerik Pharmaceuticals62%38%
Male
Female

Compare race at BioNumerik Pharmaceuticals vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
41%18%8%31%3%
7.1
58%9%7%22%5%
9.2

BioNumerik Pharmaceuticals and similar companies CEOs

CEOBio
Stephen Linthwaite (Chris)
Fluidigm

Chris Linthwaite joined Fluidigm in August 2016 as President and Chief Operating Officer, and was named Chief Executive Officer in October 2016. Previously, he served as President of the Genetic Sciences Division at Thermo Fisher Scientific and President of the BioProduction Division at Life Technologies. He received an MBA and a BA from the University of Virginia.

Paris Panayiotopoulos
Ariad Pharmaceuticals

Cory Roberts
Cato Research

BioNumerik Pharmaceuticals competitors FAQs

Search for jobs